MAP2K7 and breast carcinoma: In the study by Zhang et al., a high concentration (10 μM) of PLX7904 did not activate MEK-ERK signalling in A431 epidermoid carcinoma, SKBR3 breast cancer, and B9 cutaneous squamous cell carcinoma cell lines, all of which express wildtype BRAF17.